Amgen Inc (NAS:AMGN)
$ 308.45 -1.7 (-0.55%) Market Cap: 165.46 Bil Enterprise Value: 220.69 Bil PE Ratio: 44.06 PB Ratio: 32.95 GF Score: 89/100

Amgen Inc at TD Cowen Health Care Conference Transcript

Mar 05, 2024 / 02:10PM GMT
Release Date Price: $276.65 (-0.98%)
Yaron Benjamin Werber
TD Cowen, Research Division - MD & Senior Biotechnology Analyst

All right. Well, welcome once again to the 44th Annual TD Cowen Healthcare Conference. I'm Yaron Werber from the Biotech team, and it's a great pleasure to moderate the fireside chat next with Amgen, first fireside chat for the day, so have very high expectations. With us today is Peter Griffith, the[LM1]Chief Financial Officer; Paul Burton, Chief Medical Officer; Justin Claeys, VP of IR; Casey in the audience as well. So gentlemen, thanks for joining us. We appreciate it. Peter, let me turn it over to you opening remarks, and then we'll dive into Q&A.

Peter H. Griffith
Amgen Inc. - Executive VP & CFO

Thank you, Yaron. Thank you, TD Cowen. It's great to be here at the 44th conference. Listen, we're here today on behalf of 27,000 plus colleagues at Amgen. Our mission is to serve patients. And this is an exciting time for Amgen. We see significant long-term growth opportunities across all 4 of our therapeutic pillars.

Numerous catalysts this year,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot